Delivery Order SPE2DB22D3016-SPE2DB25FBGJ3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,815.80 for Dexmethylphenidate ER 10 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexmethylphenidate is a central nervous system stimulant commonly...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Dexmethylphenidate ER 10 mg capsules in a quantity of 100 units at a ceiling value of $3,265.34. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, reflecting the vendor's established capability to meet federal pharmaceutical procurement requirements through open competition. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dexmethylphenidate ER 5 mg capsules (100-count units) with a ceiling value of $1,601.40. This firm fixed price delivery order, with an ultimate completion date of August 29, 2025, represents a pediatric neurological medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The award carries no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 15 mg capsules (100 count) valued at $2,024.24, with a performance period through August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its Conshohocken, Pennsylvania corporate office location. The award represents a pediatric neurological medication commonly used to treat attention deficit...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,494.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 28, 2025, with performance fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100-count) valued at $3,244.14 under a firm fixed price contract. The award, made on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) valued at $3,238.65. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The contract calls for ultimate completion by July 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,226.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 30 mg capsules (100 count) on August 5, 2025, with a ceiling value of $2,111.70 and an ultimate completion date of August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a contract value of $1,250.14. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The work is to be completed by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGJ3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 5 mg capsules (100-count) valued at $2,275.58 under a firm fixed price contract type. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025. No set-aside designation was used for this procurement, indicating the award resulted from open competition. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dexmethylphenidate, a central nervous system stimulant used in treating attention deficit hyperactivity disorder, represents one of the numerous pharmaceutical products the contractor supplies through this strategic contract vehicle to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/27/25 |